col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


32 Results       Page 1

 [1] 
Springer-Verlag: Drugs
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―23 Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines Congrui Zhu, Shengmei Pang, Jiaqi Liu, Qiangde Duan
2 [GO] 2023―Dec―18 Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study” Wen-Bin Yeh, Wei-Kai Lee, Hui-Yuan Chen, Su-Boon Yong, Cheuk-Kwan Sun
3 [GO] 2023―Dec―18 Comment on: “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study” Tsung-Wei Chang, Cheng-Hsien Hung
4 [GO] 2023―Dec―18 Reply to the Comments on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study” Thomas Yen-Ting Chen, Qianru Zhang, Yao-Min Hung, Renin Chang, Shiow-Ing Wang, James Cheng-Chung Wei
5 [GO] 2023―Sep―04 Correction to: Remdesivir: A Review in COVID-19 Hannah A. Blair
6 [GO] 2023―Aug―17 Remdesivir: A Review in COVID-19 Hannah A. Blair
7 [GO] 2023―May―19 Correction to: Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study Thomas Yen-Ting Chen, Shiow-Ing Wang, Yao-Min Hung, Joshua J. Hartman, Renin Chang, James Cheng-Chung Wei
8 [GO] 2023―May―11 Correction to: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’ Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
9 [GO] 2023―May―11 Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study Thomas Yen-Ting Chen, Shiow-Ing Wang, Yao-Min Hung, Joshua J. Hartman, Renin Chang, James Cheng-Chung Wei
10 [GO] 2023―May―04 Authors’ Reply to Chia Siang Kow et al.: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?’ Alexia Plocque, Francois Philippart
11 [GO] 2023―May―04 Interleukin-6 Receptor Inhibitors and long COVID Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
12 [GO] 2023―Jan―24 Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study Junqing Xie, James T. Brash, Cigdem Turkmen, Stefan Driessen, Giustino Varrassi, George Argyriou, et al. (+3)
13 [GO] 2022―Dec―12 Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far? Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, Francois Philippart
14 [GO] 2022―Dec―07 The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis Brett D. Edwards, Stephen K. Field
15 [GO] 2022―Feb―12 Comment on: “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence” Mario Gennaro Mazza, Benedetta Vai, Livia De Picker, Francesco Benedetti, Raffaella Zanardi
16 [GO] 2022―Feb―12 Authors’ Reply to Mazza et al.: “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence” Eric J. Lenze, Angela M. Reiersen, Shelley N. Facente
17 [GO] 2021―Dec―16 Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19 John G. Rizk, Cachet Wenziger, Diana Tran, Leila Hashemi, Hamid Moradi, Elani Streja, Amrita Ahluwalia
18 [GO] 2021―Dec―01 Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence Shelley N. Facente, Angela M. Reiersen, Eric J. Lenze, David R. Boulware, Jeffrey D. Klausner
19 [GO] 2021―Aug―28 Reply to Zhang and Zhu “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19” Nadine Ahmed, John Paul Pezacki
20 [GO] 2021―Aug―28 Comment on: “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19” Song Zhang, Feng Zhu
21 [GO] 2021―May―28 Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry” Alpo Vuorio, Petri T. Kovanen
22 [GO] 2021―Mar―29 Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry José David Torres-Peña, Luis M. Pérez-Belmonte, Francisco Fuentes-Jiménez, Mª Dolores López Carmona, Pablo Pérez-Martinez, José López-Miranda, et al. (+19)
23 [GO] 2021―Mar―08 BNT162b2 mRNA COVID-19 Vaccine: First Approval Yvette N. Lamb
24 [GO] 2021―Feb―27 MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19 Christine Hum, Julia Loiselle, Nadine Ahmed, Tyler A. Shaw, Caroline Toudic, John Paul Pezacki
25 [GO] 2020―Nov―05 Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity Kueiyu Joshua Lin, Sebastian Schneeweiss, Helen Tesfaye, Elvira D’Andrea, Jun Liu, Joyce Lii, et al. (+2)
26 [GO] 2020―Oct―17 Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review Fabrizio Cantini, Delia Goletti, Linda Petrone, Saied Najafi Fard, Laura Niccoli, Rosario Foti
27 [GO] 2020―Sep―03 Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19” Dimitrios A. Vrachatis, Sotiria G. Giotaki, George Giannopoulos, Spyridon Deftereos, Bernhard Reimers
28 [GO] 2020―Sep―03 Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19” John G. Rizk, Kamyar Kalantar-Zadeh, Mandeep R. Mehra, Carl J. Lavie, Youssef Rizk, Donald N. Forthal
29 [GO] 2020―Aug―16 Management of Thrombotic Complications in COVID-19: An Update Adrija Hajra, Sheetal Vasundara Mathai, Somedeb Ball, Dhrubajyoti Bandyopadhyay, Maedeh Veyseh, Sandipan Chakraborty, et al. (+2)
30 [GO] 2020―Jul―23 Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? Vanessa Bianconi, Francesco Violi, Francesca Fallarino, Pasquale Pignatelli, Amirhossein Sahebkar, Matteo Pirro
31 [GO] 2020―Jul―21 Pharmaco-Immunomodulatory Therapy in COVID-19 John G. Rizk, Kamyar Kalantar-Zadeh, Mandeep R. Mehra, Carl J. Lavie, Youssef Rizk, Donald N. Forthal
32 [GO] 2020―May―25 The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19 Nadia Panera, Alberto Eugenio Tozzi, Anna Alisi
 [1] 

32 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.010 sec